Understanding the causes and treatments of recurrent acute pancreatitis
Natural Course and Therapeutic Effect of Recurrent Acute Pancreatitis: a Prospective Cohort Study
This study is trying to find out what causes recurrent acute pancreatitis and whether treatments like endoscopy, surgery, or conservative care can help prevent it from coming back.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Sex | All |
| Sponsor | Changhai Hospital Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Trial ID | NCT06355206 on ClinicalTrials.gov |
What this trial studies
This observational cohort study aims to investigate the etiology, natural progression, and therapeutic effects of recurrent acute pancreatitis (RAP). It will assess whether endoscopic intervention, surgery, or conservative treatment can reduce the recurrence of acute pancreatitis and identify risk factors associated with its recurrence. Patients will be closely monitored, and their clinical information will be systematically recorded to provide insights into the condition's management and outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with recurrent acute pancreatitis.
Not a fit: Patients who are unwilling or unable to provide consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies for patients suffering from recurrent acute pancreatitis.
How similar studies have performed: While there have been studies on acute pancreatitis, this specific observational approach focusing on recurrent cases and treatment efficacy is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with recurrent acute pancreatitis. Exclusion Criteria: * Unwilling or unable to provide consent.
Where this trial is running
Shanghai, Shanghai Municipality
- Changhai Hospital — Shanghai, Shanghai Municipality, China (Recruiting)
Study contacts
- Study coordinator: Lianghao Hu, M.D.
- Email: lianghao-hu@smmu.edu.cn
- Phone: +86-13817593520
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.